Shares of BTG plc (LON:BTG – Get Free Report) traded up 0.1% during trading on Thursday . The company traded as high as GBX 840 ($10.60) and last traded at GBX 840 ($10.60). 271,742 shares traded hands during trading, a decline of 72% from the average session volume of 960,389 shares. The stock had previously closed at GBX 839 ($10.59).
BTG Price Performance
The business’s fifty day moving average is GBX 840 and its 200 day moving average is GBX 840. The stock has a market cap of £3.26 billion and a PE ratio of 29.47.
BTG Company Profile
BTG plc acquires, develops, manufactures, and commercializes pharmaceutical products in the United States, Europe, and internationally. It operates through three segments: Interventional Medicine, Pharmaceuticals, and Licensing. The Interventional Medicine segment offers interventional oncology products and systems, such as beads and TheraSphere for treatment of liver cancer; and GALIL medical system, a cryoablation technology for use in kidney cancer and other indications.
Featured Articles
- Five stocks we like better than BTG
- Ride Out The Recession With These Dividend Kings
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Texas Instruments: The Old-School Tech Titan Still Delivering
- NYSE Stocks Give Investors a Variety of Quality Options
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for BTG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BTG and related companies with MarketBeat.com's FREE daily email newsletter.
